Active substance:
- Rabbit haemorrhagic disease virus VP1A
- Rabbit haemorrhagic disease virus 2 VP1AB
Route of administration:
-
Subcutaneous use
Pharmaceutical form:
-
Suspension for injection
Target species:
-
Rabbit